ProCE Banner Activity

Emerging Therapies and Novel Approaches Targeting BCMA in Myeloma

Slideset Download
Download this short summary slideset of key topics in the evolving use of BCMA-targeted therapies for heavily pretreated relapsed/refractory multiple myeloma.

Released: October 23, 2020

Expiration: October 22, 2021

No longer available for credit.

Share

Faculty

Natalie S. Callander

Natalie S. Callander, MD

Professor of Medicine
School of Medicine and Public Health
University of Wisconsin
Director, Myeloma Clinical Program
University of Wisconsin Carbone Cancer Center
Madison, Wisconsin

Provided by

Provided by Clinical Care Options, LLC
ProCE Banner

Supporters

Supported by educational grants from

Amgen, Inc.

Celgene

Faculty Disclosure

Primary Author

Natalie S. Callander, MD

Professor of Medicine
School of Medicine and Public Health
University of Wisconsin
Director, Myeloma Clinical Program
University of Wisconsin Carbone Cancer Center
Madison, Wisconsin